Aetna considers navigated transcranial magnetic stimulation experimental and investigational for motor function mapping and / or treatment planning of neurological diseases / disorders (e.g., amyotrophic lateral sclerosis, epilepsy, and
resection of
brain tumors) because its value and effectiveness has not been established.